End-Stage Renal DiseaseNCT06982573
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD
A study testing Effects of applying magnetic stimulation in people with End-Stage Renal Disease, run by Bundang CHA Hospital at 1 site in South Korea.
Trial summary
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- End-Stage Renal Disease
- What is being tested?
- Effects of applying magnetic stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 18 participants
- Where
- 1 siteSouth Korea
- Study dates
- 6 Aug 2025to 19 Feb 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 19 years or older
- Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week
- Back pain intensity of 4 points or higher on the visual analogue scale (VAS)
- Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) [14]
- Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions
Who cannot join
- If the pain is due to trauma
- If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.
- Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).
- Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection
- Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant)
- If there are contraindications to magnetic stimulation
Show all 12Show fewer
- Patients with implanted medical devices (e.g. pacemakers)
- Metal objects are inserted into the skull
- A wound on the skin at the attachment site
- History of epilepsy
- Cervical pain or musculoskeletal disease
- Pregnant and lactating women
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
South Korea1 site, 1 recruiting
- Recruiting
CHA Bundang Medical Center, CHA University
Seongnam-si, Gyeonggi-do, 463-712
Minyoung Kim, M.D., Ph.D., 82-31-780-1872, kmin@cha.ac.kr
About this study
Official title: The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With End-Stage Renal Disease (ESRD)
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.
- Conditions
- End-Stage Renal Disease
- Being tested
- Effects of applying magnetic stimulation
- Medical subject headings
- Kidney Failure, Chronic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Effects of applying magnetic stimulationDevice
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients with End-Stage Renal Disease (ESRD)
| Study group | Role | What they receive |
|---|---|---|
| End-Stage Renal Disease patients | Experimental | Not described Receives: Device: Effects of applying magnetic stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analogue Sclae (VAS)
An assessment in which the subject quantifies the level of pain numerically from 0 to 10. The higher the number, the more intense the pain.
Measured: 7 days before intervention/1 day after intervention/1 month after intervention
Secondary outcomes (4)
Short Physical Performance Battery (SPPB)
Measures balance, lower extremity strength, and functional ability on a scale of 0 to 16. Higher scores indicate better function.
Measured: 7 days before intervention/1 day after intervention/1 month after intervention
The World Health Organization (WHOQOL-BREF)
The WHOQOL-BREF consists of 26 items, with scores ranging from 1 to 5. A higher score indicates a higher quality of life.
Measured: 7 days before intervention/1 day after intervention/1 month after intervention
3D Motion Capture
Collecting human body movement data using a 3D infrared camera and ground reaction force device
Measured: 7 days before intervention/1 day after intervention/1 month after intervention
Dual Energy X-ray Absorptionmetry (DEXA)
A test that measures muscle mass by utilizing the energy absorption properties of high-energy and low-energy X-rays.
Measured: 7 days before intervention/1 day after intervention/1 month after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 May 2025
- Study start6 Aug 2025
- Primary completion19 Feb 2026 (estimated)
- Study completion19 Feb 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for End-Stage Renal DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 18 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bundang CHA Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, MinYoung Kim, MD, PhD, Bundang CHA Hospital
- Investigators
- Kim Minyoung, M.D., Ph.D, Principal investigator, Bundang CHA Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06982573
- Sponsor's protocol ID
- 2025-01-031
- Status last verified
- Sep 2025
- First submitted
- 11 May 2025
- Last updated
- 19 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With End-Stage Renal Disease (ESRD)
- ClinicalTrials.gov ID
- NCT06982573
- Acronym / sponsor ID
- 2025-01-031
- Conditions
- End-Stage Renal Disease
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 18 participants (estimated)
- Lead sponsor
- Bundang CHA HospitalUniversity, hospital or other
- Study start
- 6 Aug 2025 (actual)
- Primary completion
- 19 Feb 2026 (estimated)
- Study completion
- 19 Feb 2026 (estimated)
- First posted
- 21 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| End-Stage Renal Disease patients | Experimental | Device: Effects of applying magnetic stimulation |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adults aged 19 years or older
- Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week
- Back pain intensity of 4 points or higher on the visual analogue scale (VAS)
- Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) [14]
- Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions
Key exclusion criteria (12 listed)
- If the pain is due to trauma
- If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.
- Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).
- Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection
- Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Effects of applying magnetic stimulationThe Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients with End-Stage Renal Disease (ESRD) | Device | End-Stage Renal Disease patients |
Primary outcome
Visual Analogue Sclae (VAS)
Time frame: 7 days before intervention/1 day after intervention/1 month after intervention
An assessment in which the subject quantifies the level of pain numerically from 0 to 10. The higher the number, the more intense the pain.
4 secondary outcomes
Short Physical Performance Battery (SPPB)
Time frame: 7 days before intervention/1 day after intervention/1 month after intervention
The World Health Organization (WHOQOL-BREF)
Time frame: 7 days before intervention/1 day after intervention/1 month after intervention
3D Motion Capture
Time frame: 7 days before intervention/1 day after intervention/1 month after intervention
Dual Energy X-ray Absorptionmetry (DEXA)
Time frame: 7 days before intervention/1 day after intervention/1 month after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for End-Stage Renal Disease
Active, not recruitingPhase 2
Safety and Efficacy of Empagliflozin in Hemodialysis
End Stage Renal Disease
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingObservational study
Physical Impairments in Children With Chronic Renal Failure
Chronic Kidney Failure, Chronic Kidney Diseases
RecruitingPhase 1
A Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
End Stage Renal Disease on Dialysis, Adult
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kim Minyoung, M.D., Ph.D principal investigator
Bundang CHA Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Effects of applying magnetic stimulation in people with End-Stage Renal Disease, run by Bundang CHA Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chung Eun Hye, M.S (+821032657071 ext. 8867, a230419@chamc.co.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analogue Sclae (VAS) (time frame: 7 days before intervention/1 day after intervention/1 month after intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.